BIONDVAX PHARMACEUTICALS-ADR (BVXV) Stock Earnings & Estimates
NASDAQ:BVXV - US09073Q2049 - ADR
1.36 USD
+0.05 (+3.82%)
1.38 USD
+0.02 (+1.47%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | |||||||||
| EBITDA YoY % growth | -7.46M | -10.67M -43.03% | -11.28M -5.72% | -23.22M -105.85% | -76.81M -230.79% | -76.7M 0.14% | 9.77M 112.74% | -8.878M -190.87% | N/A | N/A | N/A | |
| EBIT YoY % growth | -8.14M | -11.3M -38.82% | -11.9M -5.31% | -23.66M -98.82% | -77.07M -225.74% | -78.35M -1.66% | 7.33M 109.36% | -9.516M -229.83% | N/A -43.64% | N/A 6.03% | N/A -58.82% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A 98.72% | N/A -1,200.00% | N/A 61.54% | N/A 104.90% | -1.26 -5,136.00% | N/A -240.27% | N/A 99.29% | N/A -8,400.00% | N/A 92.16% |
All data in USD
| Q3 / 23 | Q4 / 23 | |
|---|---|---|
| EPS Q2Q % growth | -1.01 -10,198.00% | -1.13 -1,010.00% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -2.907M -384.39% | -3.06M 4.00% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -1.11 -455.00% | -0.93 | -0.18 | -19.59% |
| Q1 2023 Q2Q % growth | -1.09 45.50% | -0.74 | -0.35 | -46.39% |
| Q4 2022 Q2Q % growth | 96.22% | -0.10 | % | |
| Q3 2022 Q2Q % growth | 0.01 | -0.10 | 0.11 | 109.80% |
| Q2 2022 Q2Q % growth | -0.20 -519.22% | -1.07 | 0.87 | 81.33% |
| Q1 2022 Q2Q % growth | -2.00 -12,272.16% | -1.02 | -0.98 | -96.08% |
| Q4 2021 Q2Q % growth | -2.70 -29,900.00% | -0.87 | -1.83 | -211.42% |
| Q2 2021 Q2Q % growth | -0.03 99.72% | % | ||
| Q1 2021 Q2Q % growth | -0.02 98.38% | % | ||
| Q4 2020 Q2Q % growth | -0.01 | -0.01 | 0.00 | 11.76% |
| Q3 2020 Q2Q % growth | -0.01 99.88% | -0.01 | 0.00 | 1.96% |
| Q2 2020 Q2Q % growth | -11.40 44.12% | -0.10 | -11.30 | -11,076.47% |
| Q1 2020 Q2Q % growth | -1.00 -2,600.00% | -0.10 | -0.90 | -880.39% |
| Q3 2019 Q2Q % growth | -8.00 | -0.31 | -7.69 | -2,514.38% |
| Q2 2019 Q2Q % growth | -20.40 | -0.20 | -20.20 | -9,900.00% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |